Follow
Boris Reva
Boris Reva
Computation Biology Center, Memorial Sloan-Kettering Cancer Center
Verified email at cbio.mskcc.org
Title
Cited by
Cited by
Year
The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data
E Cerami, J Gao, U Dogrusoz, BE Gross, SO Sumer, BA Aksoy, ...
Cancer discovery 2 (5), 401-404, 2012
153102012
Comprehensive molecular portraits of human breast tumours
Brigham & Women’s Hospital & Harvard Medical School Chin Lynda 9 11 Park ...
Nature 490 (7418), 61-70, 2012
113272012
Comprehensive molecular characterization of human colon and rectal cancer
Cancer Genome Atlas Network
Nature 487 (7407), 330, 2012
76852012
Comprehensive genomic characterization defines human glioblastoma genes and core pathways.
CGAR Network
nature 455, 1061-8, 2008
75132008
Integrated genomic analyses of ovarian carcinoma
Cancer Genome Atlas Research Network
Nature 474 (7353), 609, 2011
70272011
The somatic genomic landscape of glioblastoma
CW Brennan, RGW Verhaak, A McKenna, B Campos, H Noushmehr, ...
cell 155 (2), 462-477, 2013
51162013
Integrated genomic characterization of endometrial carcinoma
DA Levine, ...
Nature 497 (7447), 67-73, 2013
50742013
Integrative genomic profiling of human prostate cancer
BS Taylor, N Schultz, H Hieronymus, A Gopalan, Y Xiao, BS Carver, ...
Cancer cell 18 (1), 11-22, 2010
41102010
Comprehensive genomic characterization of squamous cell lung cancers
Cancer Genome Atlas Research Network
Nature 489 (7417), 519, 2012
37452012
Comprehensive molecular characterization of clear cell renal cell carcinoma
Cancer Genome Atlas Research Network Analysis working group: Baylor College ...
Nature 499 (7456), 43-49, 2013
29072013
Comprehensive molecular characterization of urothelial bladder carcinoma
Cancer Genome Atlas Research Network
Nature 507 (7492), 315, 2014
27032014
Predicting the functional impact of protein mutations: application to cancer genomics
B Reva, Y Antipin, C Sander
Nucleic acids research 39 (17), e118-e118, 2011
22122011
Subtype-specific genomic alterations define new targets for soft-tissue sarcoma therapy
J Barretina, BS Taylor, S Banerji, AH Ramos, M Lagos-Quintana, ...
Nature genetics 42 (8), 715-721, 2010
8032010
The nuclear deubiquitinase BAP1 is commonly inactivated by somatic mutations and 3p21. 1 losses in malignant pleural mesothelioma
M Bott, M Brevet, BS Taylor, S Shimizu, T Ito, L Wang, J Creaney, RA Lake, ...
Nature genetics 43 (7), 668-672, 2011
8012011
The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov 2: 401–404
E Cerami, J Gao, U Dogrusoz, BE Gross, SO Sumer, BA Aksoy, ...
6612012
p53 regulates hematopoietic stem cell quiescence
Y Liu, SE Elf, Y Miyata, G Sashida, Y Liu, G Huang, S Di Giandomenico, ...
Cell stem cell 4 (1), 37-48, 2009
6472009
A specificity map for the PDZ domain family
R Tonikian, Y Zhang, SL Sazinsky, B Currell, JH Yeh, B Reva, HA Held, ...
PLoS biology 6 (9), e239, 2008
5662008
Proteogenomic characterization reveals therapeutic vulnerabilities in lung adenocarcinoma
MA Gillette, S Satpathy, S Cao, SM Dhanasekaran, SV Vasaikar, K Krug, ...
Cell 182 (1), 200-225. e35, 2020
5172020
EGFR Exon 20 Insertion Mutations in Lung Adenocarcinomas: Prevalence, Molecular Heterogeneity, and Clinicopathologic Characteristics
ME Arcila, K Nafa, JE Chaft, N Rekhtman, C Lau, BA Reva, MF Zakowski, ...
Molecular cancer therapeutics 12 (2), 220-229, 2013
5012013
Integrated proteogenomic characterization of clear cell renal cell carcinoma
DJ Clark, SM Dhanasekaran, F Petralia, J Pan, X Song, Y Hu, ...
Cell 179 (4), 964-983. e31, 2019
4962019
The system can't perform the operation now. Try again later.
Articles 1–20